Trial Outcomes & Findings for Clinical Evaluation of a Manufacturing Process for a Frequent Replacement Silicone Hydrogel Multifocal Contact Lens (NCT NCT05765227)

NCT ID: NCT05765227

Last Updated: 2024-04-16

Results Overview

VA was assessed binocularly (both eyes together) using a letter chart and measured in logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with lower logMAR values indicating better visual acuity. No hypothesis testing was prespecified for this endpoint.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

18 participants

Primary outcome timeframe

Day 2, each study lens type worn during the corresponding crossover period

Results posted on

2024-04-16

Participant Flow

Participants were recruited from 1 investigative site located in 1 country (US).

Of the 18 enrolled, 1 participant was exited prior to study start as a screen failure. This reporting group includes all participants exposed to any study lenses evaluated in this study (17).

Participant milestones

Participant milestones
Measure
LID#224381, Then AOHG MF
Lehfilcon A multifocal contact lenses worn first, with lotrafilcon B multifocal contact lenses worn second in pre-determined order. Each study lens type was worn bilaterally (in both eyes) for approximately 2 days in a daily wear modality. CLEAR CARE was used for nightly cleaning and disinfection.
AOHG MF, Then LID#224381
Lotrafilcon B multifocal contact lenses worn first, with lehfilcon A multifocal contact lenses worn second in pre-determined order. Each study lens type was worn bilaterally (in both eyes) for approximately 2 days in a daily wear modality. CLEAR CARE was used for nightly cleaning and disinfection.
First Wear Period (Approx. 2 Days)
STARTED
8
9
First Wear Period (Approx. 2 Days)
COMPLETED
8
9
First Wear Period (Approx. 2 Days)
NOT COMPLETED
0
0
Second Wear Period (Approx. 2 Days)
STARTED
8
9
Second Wear Period (Approx. 2 Days)
COMPLETED
8
9
Second Wear Period (Approx. 2 Days)
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Clinical Evaluation of a Manufacturing Process for a Frequent Replacement Silicone Hydrogel Multifocal Contact Lens

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
LID#224381, Then AOHG MF
n=8 Participants
Lehfilcon A multifocal contact lenses worn first, with lotrafilcon B multifocal contact lenses worn second in pre-determined order. Each study lens type was worn bilaterally (in both eyes) for approximately 2 days in a daily wear modality. CLEAR CARE was used for nightly cleaning and disinfection.
AOHG MF, Then LID#224381
n=9 Participants
Lotrafilcon B multifocal contact lenses worn first, with lehfilcon A multifocal contact lenses worn second in pre-determined order. Each study lens type was worn bilaterally (in both eyes) for approximately 2 days in a daily wear modality. CLEAR CARE was used for nightly cleaning and disinfection.
Total
n=17 Participants
Total of all reporting groups
Age, Continuous
64.1 years
STANDARD_DEVIATION 4.3 • n=99 Participants
62.4 years
STANDARD_DEVIATION 5.2 • n=107 Participants
63.2 years
STANDARD_DEVIATION 4.7 • n=206 Participants
Sex: Female, Male
Female
3 Participants
n=99 Participants
1 Participants
n=107 Participants
4 Participants
n=206 Participants
Sex: Female, Male
Male
5 Participants
n=99 Participants
8 Participants
n=107 Participants
13 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
8 Participants
n=99 Participants
9 Participants
n=107 Participants
17 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race/Ethnicity, Customized
White
7 Participants
n=99 Participants
7 Participants
n=107 Participants
14 Participants
n=206 Participants
Race/Ethnicity, Customized
Black or African American
1 Participants
n=99 Participants
2 Participants
n=107 Participants
3 Participants
n=206 Participants
Race/Ethnicity, Customized
American Indian or Alaska Native
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race/Ethnicity, Customized
Asian
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race/Ethnicity, Customized
Native Hawaiian or Other Pacific Islander
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race/Ethnicity, Customized
Other
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants

PRIMARY outcome

Timeframe: Day 2, each study lens type worn during the corresponding crossover period

Population: This analysis population includes all subjects/eyes exposed to any study lenses evaluated in this study.

VA was assessed binocularly (both eyes together) using a letter chart and measured in logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with lower logMAR values indicating better visual acuity. No hypothesis testing was prespecified for this endpoint.

Outcome measures

Outcome measures
Measure
LID#224381
n=17 Participants
Lehfilcon A multifocal contact lenses worn during first wear period or second wear period, as pre-determined.
AOHG MF
n=17 Participants
Lotrafilcon B multifocal contact lenses worn during first wear period or second wear period, as pre-determined.
Binocular Visual Acuity (VA) With Study Lenses at 4 Meters (logMAR)
-0.08 logMAR
Standard Deviation 0.06
-0.06 logMAR
Standard Deviation 0.06

Adverse Events

Pretreatment

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

LID#224381 Ocular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

LID#224381 Nonocular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

AOHG MF Ocular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

AOHG MF Nonocular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Sr. Clinical Project Lead, Vision Care

Alcon Research, LLC

Phone: 1-888-451-3937

Results disclosure agreements

  • Principal investigator is a sponsor employee Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
  • Publication restrictions are in place

Restriction type: OTHER